ONO-1110 clinical trials
Also written ONO-1110.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2025
How each study uses ONO-1110 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- ONO-1110
- 5
By phase
A phase 1/2 study counts in both.
- Phase 2
- 5
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Studies
Open first, then newest update. How each study uses ONO-1110 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Study of ONO-1110 in Patients With Postherpetic NeuralgiaCompletedPhase 2Ono Pharmaceutical Co., Ltd.NCT06708416Written as ONO-1110
- A Study of ONO-1110 in Patients With Social Anxiety DisorderCompletedPhase 2Ono Pharmaceutical Co., Ltd.NCT06805565Written as ONO-1110
- A Study of ONO-1110 in Patients With Major Depressive DisorderCompletedPhase 2Ono Pharmaceutical Co., Ltd.NCT06792136Written as ONO-1110
- A Clinical Study of ONO-1110 in Patients With FibromyalgiaCompletedPhase 2Ono Pharmaceutical Co., Ltd.NCT06752590Written as ONO-1110
- A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial CystitisCompletedPhase 2Ono Pharmaceutical Co., Ltd.NCT06752603Written as ONO-1110